259 related articles for article (PubMed ID: 37370046)
1. A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer.
Xiang M; Gao Y; Zhou Y; Wang M; Yao X
BMC Cancer; 2023 Jun; 23(1):595. PubMed ID: 37370046
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of alanyl aminopeptidase is a robust biomarker of non-familial adenomatous polyposis and non-hereditary nonpolyposis colorectal cancer syndrome early-onset colorectal cancer.
Ha YJ; Shin YJ; Tak KH; Park JL; Kim JH; Lee JL; Yoon YS; Kim CW; Kim SY; Kim JC
Cancer Med; 2023 Apr; 12(8):10091-10104. PubMed ID: 36748835
[TBL] [Abstract][Full Text] [Related]
3. Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: A retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center.
Gao XH; Li J; Liu LJ; Zheng NX; Zheng K; Mei Z; Bai CG; Zhang W
Int J Surg; 2022 Aug; 104():106780. PubMed ID: 35850466
[TBL] [Abstract][Full Text] [Related]
4. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes and splicing events in early-onset colorectal cancer.
Marx OM; Mankarious MM; Koltun WA; Yochum GS
Front Oncol; 2024; 14():1365762. PubMed ID: 38680862
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J
Front Genet; 2022; 13():1001239. PubMed ID: 36425071
[No Abstract] [Full Text] [Related]
7. Distinct plasma molecular profiles between early-onset and late-onset colorectal cancer patients revealed by metabolic and lipidomic analyses.
Zhang S; Xu R; Hu M; Choueiry F; Jin N; Li J; Mo X; Zhu J
J Pharm Biomed Anal; 2024 Apr; 241():115978. PubMed ID: 38237540
[TBL] [Abstract][Full Text] [Related]
8. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
9. Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer.
Yang J; Zhao Y; Yuan R; Wang Y; Wang S; Chang Z; Zhao W
Eur J Med Res; 2023 Nov; 28(1):533. PubMed ID: 37986009
[TBL] [Abstract][Full Text] [Related]
10. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
11. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
13. Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location.
Chen Y; Chen Z; Huang J; Hu J; He X; Lan P; He X
Int J Clin Oncol; 2022 Apr; 27(4):749-755. PubMed ID: 35079898
[TBL] [Abstract][Full Text] [Related]
14. A five-immune-related genes-based prognostic signature for colorectal cancer.
Zhu L; Wang H; Wang Z
Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
[TBL] [Abstract][Full Text] [Related]
15. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
16. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
18. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
[TBL] [Abstract][Full Text] [Related]
19. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
Shen KY; Chen BY; Gao WC
Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
[TBL] [Abstract][Full Text] [Related]
20. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
